Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biogen Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BIIB
Nasdaq
2834
https://www.biogen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biogen Inc
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
- Mar 28th, 2024 12:00 pm
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
- Mar 26th, 2024 3:21 pm
Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know
- Mar 25th, 2024 9:50 pm
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
- Mar 25th, 2024 11:03 am
UPDATE 3-EU regulator delays decision on Eisai-Biogen Alzheimer's drug
- Mar 22nd, 2024 11:05 am
Hedge Funds and Insiders Are Buying These 10 Stocks
- Mar 21st, 2024 9:14 pm
Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?
- Mar 21st, 2024 6:18 pm
Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside
- Mar 21st, 2024 1:17 pm
Here's Why Biogen Inc. (BIIB) Gained But Lagged the Market Today
- Mar 18th, 2024 9:50 pm
25 Most Stressed Cities in the United States
- Mar 18th, 2024 2:16 pm
Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
- Mar 14th, 2024 3:30 pm
Biogen Inc. (BIIB) Stock Falls Amid Market Uptick: What Investors Need to Know
- Mar 12th, 2024 9:50 pm
20 Highest Paying Countries for Biotechnology
- Mar 11th, 2024 4:44 pm
FDA delays approval deadline for Eli Lilly's Alzheimer's drug
- Mar 8th, 2024 9:11 pm
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
- Mar 8th, 2024 4:44 pm
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
- Mar 8th, 2024 3:58 pm
Eli Lilly Alzheimer’s Drug Delayed as FDA Plans Advisory Panel Meeting
- Mar 8th, 2024 3:52 pm
Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future
- Mar 8th, 2024 3:20 pm
Biogen Inc. (BIIB) Gains But Lags Market: What You Should Know
- Mar 6th, 2024 10:45 pm
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
- Mar 6th, 2024 12:30 pm
Scroll